We are live on ! Find out more
ATRI icon

Atrion Corp

Delisted

ATRI was delisted on the 20th of August, 2024.

117 hedge funds and large institutions have $711M invested in Atrion Corp in 2017 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 39 increasing their positions, 42 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

210% more capital inflows, than outflows

Capital inflows: $59.5M | Capital outflows: $19.2M

2.32% more ownership

Funds ownership: 57.79% → 60.11% (+2.3%)

0% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 13

1% less funds holding

Funds holding: 118 → 117 (-1)

7% less repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 42

Holders
117
Holders Change
-1
Holders Change %
-0.85%
% of All Funds
2.91%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
39
Reduced
42
Closed
13
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

ATRI Hedge Fund Activity: Q2 2017 in Review

117 of the 4,023 institutional investors tracked by Wall St. Rank reported a position in Atrion Corp (ATRI) for Q2 2017, worth a combined $711M — up 44% from $495M a quarter earlier.

Fund positioning in ATRI was balanced in Q2 2017: 13 funds opened new positions, 13 closed out, 39 added to existing stakes and 42 trimmed.

The largest buyer was Columbia Wanger Asset Management, opening a new position worth an estimated $11.7M. The largest seller was Boston Trust Walden, cutting an estimated $2.9M.

  • 117 institutional investors held Atrion Corp (ATRI) as of Q2 2017, down from 118 in Q1 2017.
  • Funds reported $711M of Atrion Corp stock for Q2 2017, up 44% quarter-over-quarter.
  • 13 funds opened new Atrion Corp positions in Q2 2017 and 13 closed out, a net change of 0 holders.
  • The largest Atrion Corp buyer in Q2 2017 was Columbia Wanger Asset Management, an estimated $11.7M added.
  • The largest Atrion Corp seller in Q2 2017 was Boston Trust Walden, an estimated $2.9M sold.

Based on aggregated 13F filings for Q2 2017.